Importance Percutaneous ventricular assist devices (PVADs) provide robust hemodynamic
support compared with intra-aortic balloon pumps (IABPs), but clinical use patterns are …

Objectives This study evaluates the cost‐effectiveness of percutaneous cardiac assist device
(pVAD) therapy in the emergent setting compared with traditional surgical hemodynamic …

There has been a significant increase in the use of short-term percutaneous ventricular
assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide …

Objectives: This study sought to examine trends in mortality, readmission, and costs among
Medicare beneficiaries receiving ventricular assist devices (VADs) and associations …

High-risk percutaneous coronary intervention (PCI) is often offered to patients with extensive
coronary artery disease, decreased left ventricular function, and co-morbid conditions that …

Percutaneous ventricular assist devices (PVADs) and intraaortic balloon pump (IABP) are
used to provide mechanical circulatory support (MCS) for high-risk percutaneous coronary …

The intra-aortic balloon pump (IABP) and percutaneous ventricular assist devices (pVAD)
are commonly used in different clinical scenarios. The goal of this study was to carry out a …

We review the current evidence on the use of pVADs (Tandemheart pVAD, Impella,
percutaneous extracorporeal membrane oxygenation), their indications, relative merits, and …

Objective: A new and smaller percutaneous ventricular assist device (pVAD, Impella,
Abiomed, Danvers, MA) has been developed to provide circulatory support in …

Background: Patients with acute myocardial infarction (AMI) complicated by acute heart
failure or cardiogenic shock have high mortality with conventional management. Objectives …